Next Article in Journal
Additive Manufacturing, Thermoplastics, CAD Technology, and Reverse Engineering in Orthopedics and Neurosurgery–Applications to Preventions and Treatment of Infections
Previous Article in Journal
In Vitro Effects of Some Antibiotics on Purified β-Glucosidases from Rat Liver and Kidney Tissues
Previous Article in Special Issue
Postbiotic Metabolite Derived from Lactiplantibacillus plantarum PD18 Maintains the Integrity of Cell Barriers and Affects Biomarkers Associated with Periodontal Disease
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Molecular and Phenotypic Evaluation of Antibiotic Resistance in Enteric Rods Isolated from the Oral Cavity

1
Unidad de Investigación Básica Oral-UIBO, Vicerrectoría de Investigaciones, Facultad de Odontología, Universidad El Bosque, Bogotá 110121, Colombia
2
Facultad de Odontología, Universidad El Bosque, Bogotá 110121, Colombia
*
Author to whom correspondence should be addressed.
Antibiotics 2025, 14(6), 564; https://doi.org/10.3390/antibiotics14060564
Submission received: 28 March 2025 / Revised: 22 April 2025 / Accepted: 24 April 2025 / Published: 31 May 2025
(This article belongs to the Special Issue Periodontitis: Prevention and Treatment)

Abstract

:
Gram-negative enteric rods (GNERs) are transient members of the oral microbiota and are considered a superinfection in patients with periodontitis that poses local and systemic risks due to associations with infections and multidrug resistance, including extended-spectrum beta-lactamases. These pathogens often resist antibiotics such as amoxicillin, doxycycline, and ciprofloxacin, complicating dental treatments. Though their resistance patterns vary, links between specific resistance genes and phenotypic resistance remain unclear. Objectives: To determine the correlation between resistance genes (blaTEM, blaSHV, tetQ, tetM, qnrB, qnrS, and mph(A)) and phenotypic resistance in GNERs isolated from oral cavity samples. Methods: A total of 90 oral isolates of GNERs were isolated from patients in a dental clinic, and bacteria were identified by the BD BBL Crystal biochemical panel. The antibiotic susceptibility testing was conducted through broth microdilution following CLSI standards for drives such as amoxicillin, amoxicillin/clavulanic acid, doxycycline, ciprofloxacin, and azithromycin. Resistance genes, including blaTEM, blaSHV, tetQ, tetM, qnrS, qnrB, and mph(A), were detected using polymerase chain reaction and gel electrophoresis. The proportions of species, resistance genes, and minimum inhibitory concentration values were statistically analyzed. Conclusions: As expected, most enteric bacteria showed natural resistance to beta-lactams. Significant resistance to azithromycin was observed in some species. Genotypic and phenotypic profiles suggest the existence of alternative resistance mechanisms; therefore, other mechanisms associated with antibiotic resistance should be investigated.

1. Introduction

The Gram-negative enteric rods (GNERs) included in the family Enterobacteriaceae are commonly found in the microbiota of the gastrointestinal tract because they are natural inhabitants of soil and water. Though usually thought to be nonresidents of the oral microbiota, they can often be part of the transient microbiota, depending on the ingestion of water or food from contaminated sources or poor personal hygiene [1]. In patients with periodontitis, enteric rods are considered a superinfection [2], a multifactorial, chronic inflammatory disease characterized by dysbiotic microbiota and the loss of periodontal tissue support [3]. These pathogens can survive in the subgingival pocket, even after periodontal treatment such as debridement and surgery, contributing to refractory periodontitis, oral mucosal infections, and dental implant failure, particularly in patients who are immunosuppressed, diabetic, xerostomic, or elderly [4,5].
Recent studies have reported the frequency of enteric bacteria isolated from patients with periodontitis, observing a low frequency in Germany (5%) [2], whereas another study reported the presence of enteric bacteria in 45.9% of patients with periodontitis in Brazil [6]. Colonization of GNERs in the oral cavity poses local and systemic risks because it is associated with serious diseases such as pneumonia, meningitis, systemic infections, endocarditis, and urinary tract infections.
Furthermore, GNERs often harbor determinants of antibiotic resistance, including extended-spectrum beta-lactamases (ESBLs), aggravating public health concerns. The existence of multidrug-resistant GNER strains in the oral cavity of healthy humans highlights the importance of epidemiological surveillance to reduce their spread and associated health risks [7]. Antimicrobial resistance (AMR) is embedded in the immediate public health problem, as it is driven by indiscriminate antimicrobial overuse, which are frequently used during mechanical and surgical treatment alternatives in dentistry [2]. GNERs often show either intrinsic or acquired resistance to first-line antibiotics such as beta-lactams and metronidazole [8]. Alternatives to these drugs, such as fluoroquinolones (ciprofloxacin), macrolides (azithromycin and clarithromycin), and tetracyclines (doxycycline), have shown limited capacity to act because of the establishment of new resistance mechanisms [9].
Recent work has shown regional variations in the NRG resistance patterns. For example, in Brazil, Klebsiella pneumoniae, Escherichia coli, and Enterobacter aerogenes isolated from dentures showed resistance to amoxicillin and amoxicillin/clavulanic acid, and some isolates were resistant to tetracycline [10]. Another study detected the resistance of Enterobacteriaceae to other classes of antimicrobial agents including tetracycline (25%), sulfamethoxazole/trimethoprim (12.5%), and chloramphenicol (18.8%). No resistance to quinolones, ciprofloxacin, or norfloxacin was detected among the enteric rods isolated from the periodontal pockets [11]. In Nigeria, high frequencies of beta-lactamase genes (blaOXA, blaCTX-M, and blaSHV) have been observed in Enterobacteriaceae isolated from patients with periodontitis [12]. In Europe, Basic et al. processed oral samples from 211 Swedish patients with mucosal lesions, periodontitis, or peri-implantitis, identifying a total of 138 isolates of enteric rods, which showed high resistance to antibiotics commonly used in dentistry (amoxicillin, amoxicillin + clavulanic acid, ampicillin, clindamycin, doxycycline, erythromycin, oxacillin, penicillin V, and tetracycline); most of them were susceptible to ciprofloxacin [13]. In Poland, GERs constituted 37.4% of bacteria in oral samples from 182 healthy adolescents, 27.5% of which were resistant to multiple antibiotics such as ampicillin (100%), ceftazidime (69.1%), meropenem (60.3%), gentamicin (60.3%), piperacillin/tazobactam (52.9%), piperacillin (45.6%), amikacin (38.2%), ciprofloxacin (36.8%), trimethoprim/sulfamethoxazole (36.8%), and imipenem (29.4%) [7]. In Asia, the presence of bacteria with antibiotic resistance to third-generation cephalosporins and carbapenems, recovered from the oral cavity of patients between 40 and 90 years old, has been reported, particularly GERs resistant to cephalosporins and carbapenems in 19.5% of patients. The main genera and species found were Acinetobacter (39.7%), Stenotrophomonas (24.4%), Pseudomonas (14.5%), Enterobacter spp., (3.8%), and E. coli (3.1%). In E. coli, the presence of ESBL genes has been reported [14]. In a multicenter study conducted in Colombia, enteric bacilli were observed in 29.8% of all patients, both periodontally healthy and diseased individuals; however, their resistance patterns have not been well examined [15]. Despite this progress, the relationship between specific resistance genes and phenotypic sensitivity to antibiotics used in dentistry, namely, amoxicillin, amoxicillin/clavulanic acid, doxycycline, ciprofloxacin, and azithromycin, remains poorly understood. Therefore, the aim of this study is to determine the correlation between resistance genes (blaTEM, blaSHV, tetQ, tetM, qnrB, qnrS, and mph(A)) and phenotypic resistance in Gram-negative Enterobacteriaceae isolated from oral cavity samples.

2. Results

2.1. Frequency of Enteric Rods in Oral Isolates

In the oral cavity samples studied here, 90 bacterial isolates of different enteric species were found. The dominant species was Enterobacter cloacae with 28.9% (n = 26), followed by Klebsiella oxytoca with 21.1% (n = 19) and Cronobacter sakazakii with 15.6% (n = 14); subsequently, we found Serratia marcescens (14.4%; n = 13), Klebsiella pneumoniae (6.7%; n = 6), Serratia liquefaciens (6.7%; n = 6), Enterobacter gergoviae (5.6%; n = 5), and Klebsiella aerogenes (1.1%; n = 1) (Table 1). These findings reveal the variety of bacterial species in the oral cavity and the predominance of Enterobacter cloacae, which suggests its capacity to adapt and colonize the oral cavity.

2.2. Evaluation of Antibiotic Susceptibility in Oral Isolations of Enteric Rods

Different patterns of antibiotic resistance were observed (Table 2). Overall, 97.8% (n = 88) of species were resistant to β-lactam antibiotics such as amoxicillin (AMX), and 91.1% (n = 82) were resistant to amoxicillin/clavulanic acid (AMC). Additionally, 53.3% (n = 48) of isolates were resistant to azithromycin (AZT), 18.8% (n = 17) were resistant to doxycycline (DO), and 1.1% were resistant to ciprofloxacin (CIP). For sulfonamides, 1.4% (n = 1) of isolates were resistant to trimethoprim/sulfamethoxazole (TMP/SMX). We observed that 10% (n = 9) of the enteric bacterial isolates were simultaneously resistant to more than two antibiotics, and only one isolate was sensitive to all the antibiotics evaluated. In the 90 isolates evaluated (MIC90), the inhibition range was 8–32 µg/mL for AMX; the minimum inhibitory concentration 50 (MIC50) was 32 µg/mL, while the MIC90 was 32 µg/mL. For AMC, the inhibition range was 4–32 µg/mL, the MIC50 was 32 µg/mL, and the MIC90 was 32 µg/mL. For AZT, an inhibition range of 2–64 µg/mL was observed, the MIC50 was <32 µg/mL, and the MIC90 was 64 µg/mL. For DO, the inhibition range was 0.5–32 µg/mL, the MIC50 was 4 µg/mL, and the MIC90 was 8 µg/mL. For CIP, the inhibition range was 0.0004–32 µg/mL, the MIC50 was 0.0312 µg/mL, and the MIC90 > 0.125 µg/mL. For TMP/SMX, the inhibition range was <0.25–8 µg/mL, the MIC50 was >0.25 µg/mL, and the MIC90 > 0.25 µg/mL (Table 2).
Resistance varied across species. In particular, Enterobacter cloacae showed 100% resistance to AMX, 92.3% to AMC, 23.1% to DO, 61.5% to AZT, and no resistance to CIP. K. oxytoca showed 100% resistance to AMX and AMC, 21.1% to DO, 68.4% to AZT, and no resistance to CIP. C. sakazakii showed 100% resistance to AMX, 85.7% to AMC, 28.6% to DO, 71.4% to AZT, and no resistance to CIP. Serratia marcescens showed 100% resistance to AMX, 92.3% to AMC, 30.8% to AZT, and no resistance to DO or CIP. K. pneumoniae showed 100% resistance to AMX, 83.3% to AMC, 16.7% to CIP, 33.3% to AZT, and no resistance to DO. S. liquefaciens showed 100% resistance to AMX and AMC, 16.7% to DO, 33.3% to AZT, and no resistance to CIP. Enterobacter gergoviae showed the lowest levels of resistance: 60% to AMX; 40% to AMC; and no resistance to CIP, DO, or AZT. Klebsiella aerogenes distinguished itself by its 100% resistance to AMX, AMC, and AZT, with no resistance to CIP or DO. Generally, high resistance to AMX and AMC was observed, whereas resistance to CIP was low (Figure 1). Table 3 summarizes the ranges and MIC50 and MIC90 values for each bacterium.

2.3. Prevalence of Resistance Genes in Oral Isolates of Enteric Rods

Table 4 shows the frequency of the resistance genes in the 90 isolates. Genes associated with resistance to β-lactam antibiotics (blaTEM and blaSHV), tetracyclines (tetM and tetQ), fluoroquinolones (qnrB and qnrS), and macrolides (mph(A)) were detected in the isolates of enteric rods. The most frequently detected genes in the isolates were tetM (51.1%), blaTEM (26.6%), qnrB (17.7), and blaSHV (14.4%). Low levels of tetQ and qnrS were detected (1.1% each), while mph(A) was not detected in any of the species.
E. cloacae showed the highest frequency of tetM (57.7%), followed by blaTEM (2.1%) and blaSHV (80.8%). While qnrB (1%) and tetQ (3.8%) were detected in a lower proportion, neither qnrS nor mph(A) was detected. K. oxytoca showed a high frequency of tetM (52.6%), blaTEM (31.6%), and qnrB (36.8%). The detection of blaSHV was 21.1%, whereas tetQ, qnrS, and mph(A) were not detected. C. sakazakii showed predominance of the tetM gene (64.3%), followed by blaTEM (14.3%) and blaSHV (14.3%). qnrB (21.4%) was present, whereas tetQ, qnrS, and mph(A) were not detected. S. marcescens was present with blaTEM with a frequency of 30.8%. blaSHV (15.4%) and tetM (23.1%) were also detected, and qnrB was detected in 15.4% of isolates; tetQ, qnrS, and mph(A) were not observed. K. pneumoniae showed significant frequencies of tetM (66.7%), blaTEM (33.3%), blaSHV (16.7%), and qnrS (16.7%). tetQ, qnrB, and mph(A) were not detected. S. liquefaciens showed only tetM (16.7%). E. gergoviae showed high frequencies of tetM (80%) and blaTEM (20%). K. aerogenes showed blaTEM and blaSHV with a frequency of 100%, while other genes were not detected.

2.4. Genotype–Phenotype Relationship

Of the 90 isolates of enteric bacteria analyzed, 89 were resistant to beta-lactams, and 32 isolates harbored resistance genes. The relationship between genotype and phenotype showed notable variability across bacterial species and antibiotics (Figure 2). The connection between ARGs and the observed phenotypes was investigated, classifying the profiles into the following categories: Gp-po (gene present and resistance observed), Gp-npo (gene present but resistance not observed), Ga-po (gene absent and resistance observed), and Ga-npo (gene absent and resistance not observed). E. cloacae demonstrated high susceptibility to β-lactams; for amoxicillin, 9 isolates were categorized as Gp-po and 17 as Gp-npo, whereas 9 Gp-po and 15 Ga-po were found for amoxicillin/clavulanic acid. These results suggest alternate resistance mechanisms. Most isolates were sensitive to azithromycin (Gp-npo: 16, Ga-npo: 10), whereas the resistance rates of doxycycline and ciprofloxacin were not discrete (Ga-po: 11 and 4, respectively).
K. oxytoca showed moderate resistance to β-lactams, with amoxicillin classified as Gp-po in 1 and Ga-po in 2; conversely, amoxicillin/clavulanic acid was classified as Gp-po in 6 and Ga-po in 8. Moderate resistance to azithromycin was observed (Gp-po: 2, Ga-po: 5); in contrast, the remaining 2 Gp-po and 5 Ga-po isolates demonstrated resistance to ciprofloxacin. C. sakazakii exhibited lower resistance to β-lactams compared with other species, particularly with amoxicillin showing 3 Gp-po and 11 Gp-npo, and amoxicillin/clavulanic acid showing 2 Gp-po, 10 Gp-npo, and 1 Ga-po. Azithromycin and ciprofloxacin resistance was minimal in most isolates in the Gp-npo and Ga-npo profiles, respectively. Substantial resistance was noted against amoxicillin (Gp-po: 6, Gp-npo: 7) and amoxicillin/clavulanic acid (Gp-po: 5, Ga-po: 1) for S. marcescens. Azithromycin resistance provided a low evidence base (Ga-npo: 9), remaining nonetheless in the low resistance range for doxycycline (Ga-po: 3) and ciprofloxacin (Ga-po: 1). K. pneumoniae displayed much less resistance, with amoxicillin showing a mild response for 3 Gp-po and 3 Gp-npo, and amoxicillin/clavulanic acid being less significant, with only 2 Gp-po and 1 Ga-po. The isolates most susceptible to these antibiotics included azithromycin (Gp-npo: 4, Ga-npo: 9) and ciprofloxacin (Ga-npo: 5). S. liquefaciens was consistently susceptible to antibiotics immediately; for both azithromycin and ciprofloxacin, all isolates were still in Ga-npo. Doxycycline resistance was represented by only one isolate as Ga-po. Resistance against E. gergoviae was uncommon, with a single Gp-po isolate for the β-lactams and other isolates classified as Ga-npo for most other antibiotics. K. aerogenes showed moderate resistance to β-lactams (Gp-po: 2, Ga-po: 2); similarly, all isolates were susceptible to azithromycin and ciprofloxacin (Ga-npo).
E. cloacae and K. oxytoca had high β-lactam resistance, mostly present as Gp-po and Ga-po. Less resistant C. sakazakii and S. marcescens had mixed profiles, with occasional resistance to β-lactams and doxycycline. Lower-resistant K. pneumoniae, S. liquefaciens, E. gergoviae, and K. aerogenes showed a higher sensitivity profile, with Ga-npo being the most predominant, with occasional resistance without any detected genes (Ga-po).

3. Discussion

GNERs are transient colonizers of the oral cavity; their presence can increase the risk of systemic dissemination and serious infections, such as pneumonia, bacteremia, and endocarditis, especially in patients with immunosuppression, diabetes, advanced age, xerostomia, or other oral disorders. Furthermore, their ability to carry antibiotic resistance genes and resist various antibiotics is a significant therapeutic challenge [1].
In this study, the most prevalent bacteria identified were E. cloacae (28.9%) and K. pneumoniae (21.1%), which agrees with Goldberg et al. in 1997 [17], who associated these microorganisms with the production of compounds such as volatile sulfides and cadaverine related to bad breath. Likewise, in 2007, Botero et al. [18] described these same species as the most frequently isolated in patients with chronic periodontitis, suggesting a possible relationship between their colonization and the development of chronic periodontal disease. In 2024, Basi et al. [13] also reported these species as the most frequently isolated from patients with oral inflammatory dysbiotic conditions. In the Colombian population, Mayorga et al. [19] reported frequencies of Klebsiella, Enterobacter, and Serratia of 10–15.2%. The presence of these microorganisms in the oral cavity has been associated with poor oral hygiene or the consumption of contaminated food and water [1].
Almost all identified Enterobacteriaceae showed high resistance to beta-lactams. This study revealed that more than 90% of the isolates were resistant to amoxicillin and amoxicillin/clavulanic acid, reflecting low sensitivity to commonly used antibiotics in dental practice. Such resistance is related to intrinsic resistance mechanisms [2], associated with chromosomally encoded OXY-like beta-lactamases and mutations in the blaOXY1 and blaOXY2 promoters, which drive the overproduction of these enzymes [20]. Despite excluding patients with recent antibiotic use, resistance determinants such as plasmids and transposons exacerbate the clinical challenges caused by these bacteria. These findings underscore the urgent need for the rational use of antimicrobials in dentistry to mitigate global resistance.
For azithromycin, a high percentage of resistance was observed in oral isolates, which is consistent with Nguyen et al. [21], who found a high prevalence of bacteria resistant to this antibiotic group, mediated by the expression of different genes that inhibit its action mechanism; however, a significant percentage of sensitive enteric rods was also observed. Azithromycin resistance has been associated with various genes such as mph(A). However, in the present study, mph(A) was not detected in any of the isolates, which contrasts with Gomes et al. [22], who detected this gene in 40 of 43 isolates of enteric rods. Pawlowski et al. [23] also found mph(A) in Escherichia (50%), Klebsiella (37.5%), and Enterobacter (6.1%). Therefore, other genes associated with macrolide resistance, such as term, msr, cml, and la [24], should be evaluated.
Most isolates were susceptible to DO and CIP, which is consistent with other studies [25] that measured the prevalence and antimicrobial susceptibility of GNERs isolated from subgingival biofilm, finding high rates of susceptibility to CIP and low resistance to DO (25%) in species such as Serratia spp., Klebsiella spp., and Enterobacter spp. Although most isolates were sensitive to CIP, qnrB was found in 17.7% of them. This gene has been frequently found in enteric bacteria such as Klebsiella and Enterobacter. A significant frequency of tetM was also detected (51%), though resistance to DO was low. Tetracycline resistance genes are the most commonly found in the mouth, and tetM is the most frequently reported gene [6]. Enterobacteriaceae are considered an important gene reservoir. However, while some resistance genes may not be associated with a resistant phenotype, they can be transferred to other species or expressed under appropriate conditions [26].
This study revealed variability in genotype–phenotype relationships, highlighting the complexity of AMR mechanisms among different bacterial species and the antibiotics used. Limitations of this study include lack of knowledge of some diagnoses associated with isolates and the patient history of exposure to antibiotics. However, the categorization of the isolates into four profiles (Gp-po: gene present/resistance observed, Gp-np: gene present/resistance not observed, Ga-po: gene absent/resistance observed, and Ga-npo: gene absent/resistance not observed) helped show patterns of expected and unexpected resistance mechanisms that will guide future studies on GERs and antibiotic resistance in dental patients.

4. Materials and Methods

4.1. Sample Collection and Identification

Enteric rods were isolated from 90 oral isolates that were part of strains maintained by the oral microbiology laboratory of the UIBO Institute (Basic Oral Research Unit) collected from the saliva of patients who attended the dental clinics of El Bosque University, of whom 47.8% were diagnosed with periodontitis. Samples were preserved in BHI broth (Oxoid CM1135B, Basingstoke, UK) +10% glycerol at −80 °C, thawed, and plated on MacConkey agar (Oxoid CM10115, Basingstoke, UK) and incubated at 37 °C for 24 h. Subsequently, each genus and species were identified using the BD BBL Crystal Enteric/Nonfermented ID System biochemical panel (Becton Dickinson, Franklin Lakes, NJ, USA). Isolates were then stored in molecular-grade water at −20 °C for DNA extraction and conventional polymerase chain reaction (PCR).

4.2. Antibiotic Susceptibility Testing by Microdilution in Broth

Sterile 96-well round-bottom plates were prepared by adding 50 μL of cation-adjusted Müeller–Hinton broth (CAMBH, Becton Dickinson, Franklin Lakes, NJ, USA) to each well. The antibiotics were previously prepared as follows: amoxicillin, amoxicillin/clavulanic acid, doxycycline, ciprofloxacin, and azithromycin, according to CLSI 2022 [16]. Serial dilutions of the antibiotics were prepared from the highest to the lowest concentrations. Subsequently, dilutions of the inocula were added from the isolates of interest, which were previously adjusted in saline solution in a spectrophotometer until reaching a turbidity of 0.5 McFarland scale (625 nm OD: 0.08–0.13) to obtain a concentration equivalent to 1.5 × 108 CFU/mL.
The MIC50 and MIC90 of the isolates were determined. All plates that met the controls; purity control of the CAMBH broth; growth control; and control of the strains Escherichia coli ATCC® 25922, Enterococcus faecalis ATCC® 29212, or Staphylococcus aureus ATCC® 29213 with the antibiotics were validated according to the ranges indicated by the CLSI [16].

4.3. Detection of Antibiotic Resistance Genes by PCR

DNA was extracted by thermal shock to detect resistance genes in the enteric rod isolates. The presence of blaTEM, blaSHV, resistance to beta-lactams, tetQ, tetM, resistance to doxycycline, qnrS, qnrB, resistance to ciprofloxacin, and mph(A) resistance to macrolides was detected by conventional PCR with the primers and protocols previously reported in the literature (Table 5) with some modifications. Positive and negative controls were included.
PCR products were visualized by agarose gel electrophoresis at a concentration of 1.5% in Tris-acetate-EDTA buffer with 0.5 μg/mL of ethidium bromide in a transilluminator (Gel Doc-BioRad, Hercules, CA, USA) with ultraviolet light at 300 nm.

4.4. Statistical Analysis

Databases were built in Microsoft Office Professional Plus Excel 2016 and used to calculate Enterobacteriaceae frequencies, species frequencies, resistance genes, and antibiotic resistance (MIC50 and MIC90) to statistically analyze the results.

5. Conclusions

As expected, most enteric bacteria showed natural resistance to beta-lactams. Significant resistance to azithromycin was observed in some species, although it was not associated with the presence of resistance genes; therefore, other mechanisms related to antibiotic resistance should be investigated.
This work highlighted the high prevalence of GNERs in the oral cavity and their association with periodontitis, which increases the risk of systemic dissemination in vulnerable patients. Significant multi-resistance to the most used antibiotics in dentistry, especially β-lactams and macrolides, poses a considerable therapeutic challenge, especially when resistance genes such as tetM, blaTEM, and qnrB are present.
The variable correlation between genotypic and phenotypic profiles found here suggests the existence of alternative resistance mechanisms or rare conditions for the expression of these genes in specific niches of the oral cavity; this further highlights the need for ongoing epidemiological surveillance and the rational use of antibiotics during periodontal treatment, as well as investigations of other genetic determinants and new therapeutic alternatives that will help curb the growing threat of AMR in the context of oral and systemic health.

Author Contributions

Conceptualization, N.A.D., Y.N., N.L., P.P., M.Z., M.J., M.P. and I.L.; methodology, N.A.D., Y.N., N.L., P.P., M.Z., M.J., M.P. and I.L.; software, N.A.D. and Y.N.; validation, N.A.D. and Y.N.; formal analysis, N.A.D. and Y.N.; investigation, N.A.D. and Y.N.; resources, N.A.D. and Y.N.; data curation, N.A.D. and Y.N.; writing—original draft preparation, N.A.D. and Y.N.; writing—review and editing, N.A.D. and Y.N.; supervision, N.A.D. and Y.N.; project administration, N.A.D. and Y.N.; funding acquisition, N.A.D. and Y.N. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Vicerrectoría de Investigaciones, Universidad El Bosque.

Institutional Review Board Statement

This study was conducted on clinical isolations stored in the UIBO Institute Oral Microbiology Laboratory strain collection. The strains were isolated from patients with different oral clinical conditions in previous studies at the UIBO Institute and were donated for studies of this type. As this research is based on donated insulation, it does not require institutional ethics approval for this study specifically.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author(s).

Acknowledgments

We acknowledge Diana Marcela Castillo Perdomo, Gloria Lafaurie, Loren Rodriguez, and the students from the School of Dentistry for assisting in this study.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Zaatout, N. Presence of non-oral bacteria in the oral cavity. Arch. Microbiol. 2021, 203, 2747–2760. [Google Scholar] [CrossRef] [PubMed]
  2. Jepsen, K.; Falk, W.; Brune, F.; Cosgarea, R.; Fimmers, R.; Bekeredjian-Ding, I.; Jepsen, S. Prevalence and antibiotic susceptibility trends of selected enterobacteriaceae, enterococci, and Candida albicans in the subgingival microbiota of German periodontitis patients: A retrospective surveillance study. Antibiotics 2022, 11, 385. [Google Scholar] [CrossRef] [PubMed]
  3. Caton, J.G.; Armitage, G.; Berglundh, T.; Chapple, I.L.C.; Jepsen, S.; Kornman, K.S.; Mealey, B.L.; Papapanou, P.N.; Sanz, M.; Tonetti, M.S. A new classification scheme for periodontal and peri-implant diseases and conditions—Introduction and key changes from the 1999 classification. J. Clin. Periodontol. 2018, 49, S1–S8. [Google Scholar] [CrossRef]
  4. Edwardsson, S.; Bing, M.; Axtelius, B.; Lindberg, B.; Söderfeldt, B.; Attström, R. The microbiota of periodontal pockets with different depths in therapy-resistant periodontitis. J. Clin. Periodontol. 1999, 26, 143–152. [Google Scholar] [CrossRef]
  5. Listgarten, M.A.; Lai, C.H. Comparative microbiological characteristics of failing implants and periodontally diseased teeth. J. Periodontol. 1999, 70, 431–437. [Google Scholar] [CrossRef]
  6. Espíndola, L.C.P.; Picão, R.C.; Mançano, S.M.C.N.; Martins do Souto, R.; Colombo, A.P.V. Prevalence and antimicrobial susceptibility of gram-negative bacilli in subgingival biofilm associated with periodontal diseases. J. Periodontol. 2022, 93, 69–79. [Google Scholar] [CrossRef]
  7. Katkowska, M.; Garbacz, K.; Kwapisz, E.; Suligowska, K.; Kusiak, A.; Cichońska, D.; Świetlik, D. High oral carriage of multidrug resistant gram-negative bacilli in adolescents: The Sopkard-junior study. Front. Cell. Infect. Microbiol. 2023, 13, 13. [Google Scholar] [CrossRef]
  8. Iredell, J.; Brown, J.; Tagg, K. Antibiotic resistance in enterobacteriaceae: Mechanisms and clinical implications. BMJ 2016, 352, h6420. [Google Scholar] [CrossRef]
  9. Contaldo, M.; D’Ambrosio, F.; Ferraro, G.A.; Di Stasio, D.; Di Palo, M.P.; Serpico, R.; Simeone, M. Antibiotics in dentistry: A narrative review of the evidence beyond the myth. Int. J. Environ. Res. Public Health 2023, 20, 6025. [Google Scholar] [CrossRef]
  10. Silva, S.S.; Ribeiro, M.d.O.; Gomes, F.I.F.; Chaves, H.V.; e Silva, A.A.R.; Zanin, I.C.J.; Barbosa, F.C.B. Occurrence and antimicrobial susceptibility of enteric rods and pseudomonads isolated from the dental prostheses biofilm. J. Appl. Oral Sci. 2016, 24, 462–471. [Google Scholar] [CrossRef]
  11. Gonçalves, M.O.; Coutinho-Filho, W.P.; Pimenta, F.P.; Pereira, G.A.; Pereira, J.A.A.; Mattos-Guaraldi, A.L.; Hirata, R. Periodontal disease as reservoir for multi-resistant and hydrolytic enterobacterial species. Lett. Appl. Microbiol. 2007, 44, 488–494. [Google Scholar] [CrossRef] [PubMed]
  12. Iroha, I.R.; Mohammed, I.D.; Moses, I.B.; Ngwu, N.J.; Uzoeto, H.O.; Oladimeji, A.S.; Ikemesit, U.P.; Onuora, L.A.; Ewa, N.J.; Edemekong, C.I. Molecular characterization of enterobacteriacea isolated from gingivitis and periodontitis patients and the antimicrobial activity of mouth wash agents. Sci. Afr. 2022, 15, e01106. [Google Scholar] [CrossRef]
  13. Basic, A.; Blomqvist, S.; Charalampakis, G.; Dahlén, G. Antibiotic resistance among aerobic gram-negative bacilli isolated from patients with oral inflammatory dysbiotic conditions—A retrospective study. Front. Dent. Med. 2024, 5, 1293202. [Google Scholar] [CrossRef]
  14. Kawayanagi, T.; Kawada-Matsuo, M.; Takeshita, T.; Nguyen-Tra Le, M.; Asakawa, M.; Sugawara, Y.; Arai, C.; Ouhara, K.; Nishi, H.; Mizuno, N.; et al. The oral cavity is a potential reservoir of gram-negative antimicrobial-resistant bacteria, which are correlated with ageing and the number of teeth. Heliyon 2024, 10, e39827. [Google Scholar] [CrossRef]
  15. Lafaurie, G.I.; Contreras, A.; Barón, A.; Botero, J.; Mayorga-Fayad, I.; Jaramillo, A.; Giraldo, A.; González, F.; Mantilla, S.; Botero, A.; et al. Demographic, clinical, and microbial aspects of chronic and aggressive periodontitis in Colombia: A multicenter study. J. Periodontol. 2007, 78, 629–639. [Google Scholar] [CrossRef]
  16. CLSI. Performance Standards for Antimicrobial Susceptibility Testing, M100, 32nd ed.; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2022. [Google Scholar]
  17. Goldberg, S.; Cardash, H.; Browning, H.; Sahly, H.; Rosenberg, M. Isolation of enterobacteriaceae from the mouth and potential association with malodor. J. Dent. Res. 1997, 76, 1770–1775. [Google Scholar] [CrossRef]
  18. Botero, J.E.; Contreras, A.; Lafaurie, G.; Jaramillo, A.; Betancourt, M.; Arce, R.M. Occurrence of periodontopathic and superinfecting bacteria in chronic and aggressive periodontitis subjects in a colombian population. J. Periodontol. 2007, 78, 696–704. [Google Scholar] [CrossRef]
  19. Mayorga-Fayad, I.; Lafaurie, G.I.; Contreras, A.; Castillo, D.M.; Barón, A.; Aya, M.; Del, R. Subgingival microbiota in chronic and aggressive periodontitis in Bogotá, Colombia: An epidemiological approach. Biomédica 2007, 27, 21–33. [Google Scholar] [CrossRef]
  20. Duytschaever, G.; Huys, G.; Boulanger, L.; De Boeck, K.; Vandamme, P. Amoxicillin–clavulanic acid resistance in fecal enterobacteriaceae from patients with cystic fibrosis and healthy siblings. J. Cyst. Fibros. 2013, 12, 780–783. [Google Scholar] [CrossRef]
  21. Nguyen, M.C.P.; Woerther, P.-L.; Bouvet, M.; Andremont, A.; Leclercq, R.; Canu, A. Escherichia coli as reservoir for macrolide resistance genes. Emerg. Infect. Dis. 2009, 15, 1648–1650. [Google Scholar] [CrossRef]
  22. Gomes, C.; Martínez-Puchol, S.; Palma, N.; Horna, G.; Ruiz-Roldán, L.; Pons, M.J.; Ruiz, J. Macrolide resistance mechanisms in enterobacteriaceae: Focus on azithromycin. Crit. Rev. Microbiol. 2017, 43, 1–30. [Google Scholar] [CrossRef]
  23. Pawlowski, A.C.; Stogios, P.J.; Koteva, K.; Skarina, T.; Evdokimova, E.; Savchenko, A.; Wright, G.D. The evolution of substrate discrimination in macrolide antibiotic resistance enzymes. Nat. Commun. 2018, 9, 112. [Google Scholar] [CrossRef]
  24. Gallacher, D.J.; Zhang, L.; Aboklaish, A.F.; Mitchell, E.; Wach, R.; Marchesi, J.R.; Kotecha, S. Baseline azithromycin resistance in the gut microbiota of preterm born infants. Pediatr. Res. 2024, 95, 205–212. [Google Scholar] [CrossRef]
  25. Brooks, L.; Narvekar, U.; McDonald, A.; Mullany, P. Prevalence of antibiotic resistance genes in the oral cavity and mobile genetic elements that disseminate antimicrobial resistance: A systematic review. Mol. Oral Microbiol. 2022, 37, 133–153. [Google Scholar] [CrossRef]
  26. Deekshit, V.K.; Srikumar, S. ‘To be, or not to be’-the dilemma of “silent” antimicrobial resistance genes in bacteria. J. Appl. Microbiol. 2022, 133, 2902–2914. [Google Scholar] [CrossRef]
  27. Rasheed, J.K.; Jay, C.; Metchock, B.; Berkowitz, F.; Weigel, L.; Crellin, J.; Steward, C.; Hill, B.; Medeiros, A.A.; Tenover, F.C. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of escherichia coli during multiple episodes of bacteremia. Antimicrob. Agents Chemother. 1997, 41, 647–653. [Google Scholar] [CrossRef]
  28. Ioannidis, I.; Sakellari, D.; Spala, A.; Arsenakis, M.; Konstantinidis, A. Prevalence of tetM, tetQ, Nim and Bla(TEM) genes in the oral cavities of Greek subjects: A Pilot Study. J. Clin. Periodontol. 2009, 36, 569–574. [Google Scholar] [CrossRef]
  29. Lacroix, J.M.; Walker, C.B. Detection and incidence of the tetracycline resistance determinant tet(m) in the microflora associated with adult periodontitis. J. Periodontol. 1995, 66, 102–108. [Google Scholar] [CrossRef]
  30. Lacroix, J.M.; Walker, C.B. Detection and prevalence of the tetracycline resistance determinant tet Q in the microbiota associated with adult periodontitis. Oral Microbiol. Immun. 1996, 11, 282–288. [Google Scholar] [CrossRef]
  31. Jlili, N.E.-H.; Réjiba, S.; Smaoui, H.; Guillard, T.; Chau, F.; Kechrid, A.; Cambau, E. Trend of plasmid-mediated quinolone resistance genes at the children’s hospital in Tunisia. J. Med. Microbiol. 2014, 63, 195–202. [Google Scholar] [CrossRef]
Figure 1. Percentage of resistance to different antibiotics across several bacteria evaluated in this study. The antibiotics analyzed were amoxicillin (AMX), amoxicillin/clavulanic acid (AMC), ciprofloxacin (CIP), doxycycline (DO), and azithromycin (AZT) for the species evaluated. High resistance to AMX and AMC and minimal to no resistance to CIP was noted in all species.
Figure 1. Percentage of resistance to different antibiotics across several bacteria evaluated in this study. The antibiotics analyzed were amoxicillin (AMX), amoxicillin/clavulanic acid (AMC), ciprofloxacin (CIP), doxycycline (DO), and azithromycin (AZT) for the species evaluated. High resistance to AMX and AMC and minimal to no resistance to CIP was noted in all species.
Antibiotics 14 00564 g001
Figure 2. Molecular and phenotypic evaluation of antibiotic resistance in enteric rods. Gp-po: gene present and phenotype observed; Gp-npo: gene present but no phenotype observed; Ga-po: gene absent and phenotype observed; Ga-npo: gene absent and no phenotype observed.
Figure 2. Molecular and phenotypic evaluation of antibiotic resistance in enteric rods. Gp-po: gene present and phenotype observed; Gp-npo: gene present but no phenotype observed; Ga-po: gene absent and phenotype observed; Ga-npo: gene absent and no phenotype observed.
Antibiotics 14 00564 g002
Table 1. Species of enteric rods (n = 90) isolated from the oral cavity of patients in clinics between 2007 and 2019.
Table 1. Species of enteric rods (n = 90) isolated from the oral cavity of patients in clinics between 2007 and 2019.
OrganismsnFrequency (%)
Enterobacter cloacae2628.9
Klebsiella oxytoca1921.1
Cronobacter sakazakii1415.6
Serratia marcescens1314.4
Klebsiella pneumoniae66.7
Serratia liquefaciens66.7
Enterobacter gergoviae55.6
Klebsiella aerogenes11.1
Table 2. Global resistance and minimum inhibitory concentration (MIC) ranges, MIC50, and MIC90.
Table 2. Global resistance and minimum inhibitory concentration (MIC) ranges, MIC50, and MIC90.
AntibioticnRange 1MIC50 2MIC90 3R %
AMX908–32323297.8
AMC904–32323291.1
AZT902–>64326453.3
DO900.5–324818.8
CIP900.0004–320.03120.1251.1
TMP/SMX68<0.25–8<0.25<0.251.4
AMX: amoxicillin; AMC: amoxicillin/clavulanic acid; AZT: azithromycin; DO: doxycycline; CIP: ciprofloxacin; TMP/SMX: trimethoprim-sulfamethoxazole. 1 Antimicrobial range in which inhibition was detected (µg/mL); 2 MIC for 50% of the isolates; 3 MIC for 90% of isolates; R: resistance range (µg/mL) according to the CLSI 2022 [16] for each antibiotic evaluated.
Table 3. MIC ranges and MIC50 and MIC90 values for the antimicrobial drugs tested here.
Table 3. MIC ranges and MIC50 and MIC90 values for the antimicrobial drugs tested here.
AntibioticAMXAMCAZTCIPDO
Enterobacter cloacae
Range 1328–164–640.004–0.250.5–16
MIC50 23232320.1562
MIC90 33232320.3128
Klebsiella oxytoca
Range 116–3216–3216–640.007–0.251–32
MIC50 23232320.06254
MIC90 33232640.1258
Cronobacter sakazakii
Range 1328–164–>640.004–0.1250.5–32
MIC50 2323240.1564
MIC90 33232320.2532
Serratia marcescens
Range 1324–324–640.004–0.1250.5–8
MIC50 23232160.03122
MIC90 33232640.1254
Klebsiella pneumoniae
Range 1324–322–640.0312–321–4
MIC50 23232160.06254
MIC90 33232320.1254
Serratia liquefaciens
Range 132322–320.004–0.06250.5–16
MIC50 23232160.01560.5
MIC90 33232320.06252
Enterobacter gergoviae
Range 18–328–328–160.007–0.1252–8
MIC50 2323280.01564
MIC90 33232160.03124
Klebsiella aerogenes
Range 13232320.1254
MIC50 23232320.1254
MIC90 33232320.1254
1 Antimicrobial range in which inhibition was detected (µg/mL); 2 MIC for 50% of the isolates; 3 MIC for 90% of the isolates.
Table 4. Frequency of blaTEM, blaSHV, tetM, tetQ, qnrB, qnrS, and mph(A) in 90 oral isolates of bacterial species evaluated in this study.
Table 4. Frequency of blaTEM, blaSHV, tetM, tetQ, qnrB, qnrS, and mph(A) in 90 oral isolates of bacterial species evaluated in this study.
OrganismblaTEM F (%)blaSHV F (%)tetM
F (%)
TetQ
F (%)
qnrB
F (%)
qnrS
F (%)
mph(A)
F (%)
Enterobacter cloacae8 (2.1)3 (80.8)15 (57.7)1 (3.8)4 (1)00
Klebsiella oxytoca6 (31.6)4 (21.1)10 (52.6)07 (36.8)00
Cronobacter sakazakii2 (14.3)2 (14.3)9 (64.3)03 (21.49)00
Serratia marcescens4 (30.8)2 (15.4)3 (23.1)02 (15.4)00
Klebsiella pneumoniae2 (33.3)1 (16.7)4 (66.7)001 (16.7)0
Serratia liquefaciens001 (16.7)0000
Enterobacter gergoviae1 (20)04 (80)0000
Klebsiella aerogenes1 (100)1 (100)00000
Total24 (26.6)13 (14.4)46 (51.1)1 (1.1)16 (17.7)1 (1.1)0
Table 5. Primer sequences for detecting resistance genes.
Table 5. Primer sequences for detecting resistance genes.
GeneSequence (5′–3′)Amplicon Size (bp)Reference
mph(A)GTGAGGAGGAGCTTCGCGAG
TGCCGCAGGACTCGGAGGTC
403[21]
blaSHVTCGTTATGCGTTATATTCGCC
GGTTAGCGTTGCCAGTGCT
868[27]
blaTEMATGAGTATTCAACATTTCCG
CCAATGCTTAATCAGTGAGG
858[28]
tetMGACACGCCAGGACATATGG
TGCTTTCCTCTTGTTCGAG
397[29]
tetQGGCTTCTACGACATCTATTA
CATCAACATTTATCTCTCTG
755[30]
qnrSGGAAACCTACAATCATACATA
GTCAGGATAAACAACAATACC
657[31]
qnrBGACAGAAACAGGTTCACCGGT
CAAGACGTTCCAGGAGCAACG
594[31]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Neuta, Y.; Leguizamon, N.; Pajaro, P.; Zarate, M.; Julio, M.; Pantoja, M.; Llerena, I.; Delgadillo, N.A. Molecular and Phenotypic Evaluation of Antibiotic Resistance in Enteric Rods Isolated from the Oral Cavity. Antibiotics 2025, 14, 564. https://doi.org/10.3390/antibiotics14060564

AMA Style

Neuta Y, Leguizamon N, Pajaro P, Zarate M, Julio M, Pantoja M, Llerena I, Delgadillo NA. Molecular and Phenotypic Evaluation of Antibiotic Resistance in Enteric Rods Isolated from the Oral Cavity. Antibiotics. 2025; 14(6):564. https://doi.org/10.3390/antibiotics14060564

Chicago/Turabian Style

Neuta, Yineth, Natalia Leguizamon, Paula Pajaro, Manuela Zarate, Mauricio Julio, Manuela Pantoja, Isabella Llerena, and Nathaly Andrea Delgadillo. 2025. "Molecular and Phenotypic Evaluation of Antibiotic Resistance in Enteric Rods Isolated from the Oral Cavity" Antibiotics 14, no. 6: 564. https://doi.org/10.3390/antibiotics14060564

APA Style

Neuta, Y., Leguizamon, N., Pajaro, P., Zarate, M., Julio, M., Pantoja, M., Llerena, I., & Delgadillo, N. A. (2025). Molecular and Phenotypic Evaluation of Antibiotic Resistance in Enteric Rods Isolated from the Oral Cavity. Antibiotics, 14(6), 564. https://doi.org/10.3390/antibiotics14060564

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop